Chugai Pharmaceutical Pink Sheet Forward View
| CHGCY Stock | USD 28.62 1.10 4.00% |
Chugai Pink Sheet outlook is based on your current time horizon.
The relative strength index (RSI) of Chugai Pharmaceutical's pink sheet price is slightly above 62 suggesting that the pink sheet is rather overbought by investors at this time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Chugai, making its price go up or down. Momentum 62
Buy Extended
Oversold | Overbought |
Using Chugai Pharmaceutical hype-based prediction, you can estimate the value of Chugai Pharmaceutical Co from the perspective of Chugai Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Chugai Pharmaceutical Co on the next trading day is expected to be 28.63 with a mean absolute deviation of 0.45 and the sum of the absolute errors of 27.52. Chugai Pharmaceutical after-hype prediction price | USD 28.62 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Chugai |
Chugai Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Chugai price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Chugai using various technical indicators. When you analyze Chugai charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Chugai Pharmaceutical Naive Prediction Price Forecast For the 30th of January
Given 90 days horizon, the Naive Prediction forecasted value of Chugai Pharmaceutical Co on the next trading day is expected to be 28.63 with a mean absolute deviation of 0.45, mean absolute percentage error of 0.30, and the sum of the absolute errors of 27.52.Please note that although there have been many attempts to predict Chugai Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Chugai Pharmaceutical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Chugai Pharmaceutical Pink Sheet Forecast Pattern
| Backtest Chugai Pharmaceutical | Chugai Pharmaceutical Price Prediction | Buy or Sell Advice |
Chugai Pharmaceutical Forecasted Value
In the context of forecasting Chugai Pharmaceutical's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Chugai Pharmaceutical's downside and upside margins for the forecasting period are 26.45 and 30.82, respectively. We have considered Chugai Pharmaceutical's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Chugai Pharmaceutical pink sheet data series using in forecasting. Note that when a statistical model is used to represent Chugai Pharmaceutical pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.8976 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.4511 |
| MAPE | Mean absolute percentage error | 0.0175 |
| SAE | Sum of the absolute errors | 27.5188 |
Predictive Modules for Chugai Pharmaceutical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Chugai Pharmaceutical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Chugai Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Chugai Pharmaceutical After-Hype Price Density Analysis
As far as predicting the price of Chugai Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Chugai Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Chugai Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Chugai Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting Chugai Pharmaceutical's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Chugai Pharmaceutical's historical news coverage. Chugai Pharmaceutical's after-hype downside and upside margins for the prediction period are 26.43 and 30.81, respectively. We have considered Chugai Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Chugai Pharmaceutical is very steady at this time. Analysis and calculation of next after-hype price of Chugai Pharmaceutical is based on 3 months time horizon.
Chugai Pharmaceutical Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Chugai Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chugai Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Chugai Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.39 | 2.19 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
28.62 | 28.62 | 0.00 |
|
Chugai Pharmaceutical Hype Timeline
Chugai Pharmaceutical is currently traded for 28.62. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Chugai is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.39%. %. The volatility of related hype on Chugai Pharmaceutical is about 0.0%, with the expected price after the next announcement by competition of 28.62. The book value of the company was currently reported as 432.94. The company last dividend was issued on the 29th of June 2022. Chugai Pharmaceutical had 12:1 split on the 6th of July 2020. Assuming the 90 days horizon the next forecasted press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Chugai Pharmaceutical to cross-verify your projections.Chugai Pharmaceutical Related Hype Analysis
Having access to credible news sources related to Chugai Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Chugai Pharmaceutical's future price movements. Getting to know how Chugai Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Chugai Pharmaceutical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GLAXF | GSK plc | 0.00 | 0 per month | 2.76 | 0.08 | 6.60 | (5.63) | 16.43 | |
| DSKYF | Daiichi Sankyo | 0.00 | 0 per month | 0.00 | (0.1) | 6.37 | (6.88) | 17.89 | |
| DSNKY | Daiichi Sankyo Co | 0.00 | 0 per month | 0.00 | (0.20) | 3.96 | (4.08) | 10.19 | |
| SOAGY | Sartorius Aktiengesellschaft | 0.00 | 0 per month | 1.57 | 0.01 | 3.54 | (2.55) | 8.68 | |
| SEMHF | Siemens Healthineers AG | 0.00 | 0 per month | 0.00 | (0.03) | 4.77 | (4.91) | 11.34 | |
| MKKGY | Merck KGaA ADR | 0.00 | 0 per month | 1.36 | 0.09 | 2.89 | (2.52) | 7.85 | |
| MKGAF | MERCK Kommanditgesellschaft auf | 0.00 | 0 per month | 3.13 | 0.06 | 6.98 | (5.36) | 14.30 | |
| CMXHF | CSL Limited | 0.00 | 0 per month | 3.37 | 0.02 | 5.24 | (6.26) | 13.59 | |
| IPSEY | Ipsen SA ADR | 0.00 | 0 per month | 0.96 | 0.12 | 4.09 | (2.11) | 10.60 | |
| HOCPY | Hoya Corp | 0.00 | 0 per month | 1.79 | (0) | 2.64 | (2.41) | 9.13 |
Other Forecasting Options for Chugai Pharmaceutical
For every potential investor in Chugai, whether a beginner or expert, Chugai Pharmaceutical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Chugai Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Chugai. Basic forecasting techniques help filter out the noise by identifying Chugai Pharmaceutical's price trends.Chugai Pharmaceutical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Chugai Pharmaceutical pink sheet to make a market-neutral strategy. Peer analysis of Chugai Pharmaceutical could also be used in its relative valuation, which is a method of valuing Chugai Pharmaceutical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Chugai Pharmaceutical Market Strength Events
Market strength indicators help investors to evaluate how Chugai Pharmaceutical pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Chugai Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Chugai Pharmaceutical pink sheet market strength indicators, traders can identify Chugai Pharmaceutical Co entry and exit signals to maximize returns.
Chugai Pharmaceutical Risk Indicators
The analysis of Chugai Pharmaceutical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Chugai Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting chugai pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.71 | |||
| Semi Deviation | 1.5 | |||
| Standard Deviation | 2.19 | |||
| Variance | 4.79 | |||
| Downside Variance | 3.4 | |||
| Semi Variance | 2.26 | |||
| Expected Short fall | (1.89) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Chugai Pharmaceutical
The number of cover stories for Chugai Pharmaceutical depends on current market conditions and Chugai Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Chugai Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Chugai Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Chugai Pharmaceutical Short Properties
Chugai Pharmaceutical's future price predictability will typically decrease when Chugai Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Chugai Pharmaceutical Co often depends not only on the future outlook of the potential Chugai Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Chugai Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.3 B | |
| Cash And Short Term Investments | 472 B |
Additional Tools for Chugai Pink Sheet Analysis
When running Chugai Pharmaceutical's price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.